Vendor profile Research · US · —

Hangzhou Youngpeptide Biotechnology HYB

B+
Composite 7.9 / 10

Last updated 2026-09-28. Composite is computed from the live database; missing sub-scores redistribute weight across the others.

Lab quality
7.7
Good
Sentiment
—
—
COA
—
Limited
Reliability
—
— tenure
Pricing
10.0
Verified

Peptide breakdown

PeptideScoreLab qualityTestsPurity Qty var.$/mg verifiedLast testRanking
GHK-Cu
9.1A
8.9 4 — — — — view
Tirzepatide
8.0B+
7.5 9 — — — — view
Retatrutide
7.4B
6.7 10 — — — — view
BPC-157
—
— 0 — — — — view
MOTS-c
—
— 0 — — — — view
PT-141
—
— 0 — — — — view
Tesamorelin
—
— 0 — — — — view

COA transparency

  • ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
  • ○ Both HPLC and mass spec shown (pending)
  • ○ Endotoxin or sterility data shown (pending)
  • ○ At least one COA independently cross-checked (pending)
  • ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Hangzhou Youngpeptide Biotechnology HYB against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.